Phase 2 Nipu Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The European Medicines Agency has granted orphan drug designation to UV1 in mesothelioma.

European medicines agencyFast trackEuropean medicines agencyCancer vaccine uv1Cancer vaccineCarlos de sousaPhase 2 nipu trialOrphan drug designation